PRESS RELEASE: Sanofi and GSK join forces to fight COVID-19 BY EMMA WALMSLEY, CEO, GSK

Full Text Sharing
Submitted by Simone Galimberti 15Apr

https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-...

WATCH THE VIDE: Hear from our CEO, Emma Walmsley

Emma discusses GSK's response to COVID-19 including our collaboration with Sanofi to develop an adjuvanted COVID-19 vaccine, our commitment to access and investment in long-term pandemic preparedness.

 

The collaboration for the first time brings together the scientific and manufacturing expertise and resources of two global scale vaccines specialists to address the urgent global need for a vaccine to protect people from this disease.

The two companies expect a candidate vaccine to enter clinical trials in the second half of 2020 and, if successful and subject to regulatory considerations, aim to complete the development required for availability by the second half of 2021.

 

Share on
  • 4054 reads
Simone Galimberti
Position: Co -Founder of ENGAGE,a new social venture for the promotion of volunteerism and service and Ideator of Sharing4Good

Add new comment

More information about text formats

Filtered HTML

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Latest article

Popular article

About Us

The idea is simple: creating an open “Portal” where engaged and committed citizens who feel to share their ideas and offer their opinions on development related issues have the opportunity to do...

Read More

Contact

Please fell free to contact us. We appreciate your feedback and look forward to hearing from you.

Empowered by ENGAGE,
Toward the Volunteering Inspired Society.